Author

Zoya Shklar

Observed names: Z. Shklar, Z. Sklar, Zoya Sklar

Observed institutions: Technion – Israel Institute of Technology, Emek Medical Center, Rambam Health Care Campus, Carmel Medical Center, Carmel (Israel), Haifa Medical Center

OpenAlex ID: A5043476980

Chemotherapy-Induced Spontaneous Pneumothorax in a Patient with Bulky Mediastinal Lymphoma: A Rare Oncologic Emergency

2009 · ME. Stein, Z. Shklar, et al. · Oncology · 24

Chemoimmunohormonal Therapy With Carmustine, Dacarbazine, Cisplatin, Tamoxifen, and Interferon for Metastatic Melanoma: A Prospective Phase II Study

2002 · Moshe E. Stein, Zvi Bernstein, et al. · American Journal of Clinical Oncology · 6

Sustained Complete Remission After Chemobiohormonal Therapy for Metastatic Melanoma

1999 · Moshe E. Stein, Zvi Bernstein, et al. · American Journal of Clinical Oncology · 2

Uterine sarcoma - Accumulated 10 years experience

2005 · M. Steiner, O. Lavie, et al. · Journal of Clinical Oncology · 1

Announcement

2009 · Yoshikazu Takei, Koichi Minato, et al. · Oncology

PDF

0225 Breast carcinoma in Jewish and non-Jewish population

2009 · A. Rabkin, Z. Shklar, et al. · The Breast

0212 Triple negative breast cancer - a retrospective analysis

2009 · Z. Shklar, M. Steiner, et al. · The Breast

PDF

0021 The discrepancy between results of HER2 receptors in needle biopsy and surgical specimen of breast cancer

2009 · N. Sikorsky, L. Leitzin, et al. · The Breast

O.11 Age subgroups analysis in prostate cancer patients

2007 · Z. Shklar, A. Rabkin, et al. · Critical Reviews in Oncology/Hematology

P.36 Carboplatin/Gemzar combination in treatment NSCLC of patients age subgroup analysis

2007 · N. Sikorsky, A. Rabkin, et al. · Critical Reviews in Oncology/Hematology

P2-300: Carbo/Gem in advanced st IIIb /IV lung cancer, is it really better?

2007 · Shoshana P. Keren-Rosenberg, Ekaterina Sinatzky, et al. · Journal of Thoracic Oncology

P2-299: Carboplatin/Gemzar combination in treatment NSCLC patients: age subgroup analysis

2007 · Anna Rabkin, Susana Keren-Rosenberg, et al. · Journal of Thoracic Oncology

P165 The effect of ethnicity and life style factors on breast cancer presentation and prognosis

2007 · Z. Shklar, A. Rabkin, et al. · The Breast

P125 Adriamycin–cytoxan followed by weekly taxol as neoadjuvant treatment in localised breast cancer

2007 · M. Leviov, L. Leitzin, et al. · The Breast

P160 Breast cancer patients aged 80 years or over

2007 · A. Rabkin, Z. Sklar, et al. · The Breast

P164 Endometrial carcinoma in breast cancer patients

2007 · M. Steiner, O. Lavie, et al. · The Breast

The clinical benefit of cisplatin-doxorubicin combination in heavily pretreated ovarian cancer patients

2006 · M. Steiner, O. Lavie, et al. · Journal of Clinical Oncology

Primary hormonal therapy for patients with localized or locally advanced prostate cancer

2006 · Z. Shklar, R. Rubinov, et al. · Journal of Clinical Oncology

P87 Adriamycin Based Therapy Followed by Weekly Taxolas Neoadjuvant Treatment in Localised Breast Cancer

2005 · M. Leviov, M. Steiner, et al. · The Breast

P117 Breast carcinoma —B iologic factors and treatment approach in age groups population

2005 · A. Rabkin, Z. Sklar, et al. · The Breast

P116 Breast cancer in elderly population aged 75 years ormore

2005 · Z. Sklar, A. Rabkin, et al. · The Breast

Treatment of relapsing and refractory non-Hodgkin's lymphoma with a combination of dexamethasone, Ara-C, ifosfamide and cisplatin (DAIP)

1997 · N. Haim, M. Ben-Shahar, et al. · European Journal of Cancer

Treatment of metastatic melanoma with a combination of carmustine, dacarbazine, cisplatin, tamoxifen and interferon alpha

1997 · N. Haim, Z. Bemstein, et al. · European Journal of Cancer

Works count: 23

Citation count: 33

H-index: 2

I10-index: 1